Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|February 14, 2015
Premature ovarian failure caused by a heterozygous missense mutation in POF1B and a reciprocal translocation 46,X,t(X;3)(q21.1;q21.3)Susanne Ledig, Sabine Preisler-Adams, Susanne Morlot, et al.Journal of Medical Genetics|March 2, 2011
Sweating ability and genotype in individuals with X-linked hypohidrotic ectodermal dysplasiaHolm Schneider, Johanna Hammersen, Sabine Preisler-Adams, et al.Cancer Genetics and Cytogenetics|June 15, 2006
Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German originSabine Preisler-Adams, Ines Schönbuchner, Britta Fiebig, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 23, 2011
Hb Riesa or β93 (F9) Cys→Ser, a new electrophoretically silent haemoglobin variant interfering with haemoglobin A1c measurementEmmanuel Bissé, Agnès Hovasse, Sabine Preisler-Adams, et al.Human Molecular Genetics|July 31, 2012
Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancerTamara Hansmann, Galyna Pliushch, Monika Leubner, et al.Annals of Hematology|March 28, 2008
Haemoglobin Hokusetsu [beta52 (D3)] Asp-->Gly in German families associated with inclusion bodyEmmanuel Bissé, Nathalie Zorn, Sabine Preisler-Adams, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 23, 2008
Haemoglobin Noah Mehmet Oeztuerk (alpha(2) delta(2)143 (H21)His-->Tyr: A novel delta-chain variant in the 2,3-DPG binding siteEmmanuel Bissé, Christine Schaeffer, Agnès Hovasse, et al.International Journal of Cancer|April 13, 2011
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriersMichelle G Dick, Beatrix Versmold, Christoph Engel, et al.Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriersMonika K Graeser, Christoph Engel, Kerstin Rhiem, et al.Pageof 3